Quilizumab (INN) is a humanized monoclonal antibody designed for the treatment of asthma. It binds to IGHE.This drug was developed by Genentech.
List of articles in "Drug" category - Page 31
Patritumab
Patritumab (INN) is a human monoclonal designed for the treatment of cancer. It acts as an immunomodulator.
Inclacumab
Inclacumab (INN) is a humanized monoclonal that binds to selectin P.
Caplacizumab
Caplacizumab (INN) is a humanized monoclonal that binds to VWF.
Bezlotoxumab
Bezlotoxumab is a human monoclonal antibody designed for the prevention of recurrence of Clostridium difficile infection.This drug along with actoxumab was developed through Phase II efficacy trials by a partnership […]
Actoxumab
Actoxumab is a human monoclonal antibody designed for the prevention of recurrence of Clostridium difficile infection.This drug along with bezlotoxumab was developed through Phase II efficacy trials by a partnership […]
CBiPES
CBiPES is a drug used in scientific research that acts as a selective positive allosteric modulator for the metabotropic glutamate receptor group II subtype mGluR2. It has potentially antipsychotic effects […]
Samidorphan
Samidorphan (ALKS 33) is a selective opioid antagonist which blocks the μ-opioid receptor but without affecting the δ-opioid or κ-opioid receptors. It has been investigated for the treatment of alcoholism […]
S-444823
S-444823 is a drug developed by Shionogi which is a cannabinoid agonist. It was developed as an antipruritic and has moderate selectivity for the CB2 subtype having a CB2 affinity […]
Masitinib
Masitinib is a tyrosine-kinase inhibitor used in the treatment of mast cell tumors in animals specifically dogs. Since its introduction in November 2008 it has been distributed under the commercial […]